Targeting of the Eukaryotic Translation Initiation Factor 4A Against Breast Cancer Stemness-Reference-Cited by-同舟云学术

Targeting of the Eukaryotic Translation Initiation Factor 4A Against Breast Cancer Stemness

Published:2019-12-06 Issue: Volume:9 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Sridharan Sangita,Robeson Megan,Bastihalli-Tukaramrao Diwakar,Howard Cory M.,Subramaniyan Boopathi,Tilley Augustus M. C.,Tiwari Amit K.,Raman Dayanidhi

Funder

National Cancer Institute

Susan G. Komen

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference70 articles.

1. Cancer statistics, 2019;Siegel;CA Cancer J Clin.,2019

2. The clonal and mutational evolution spectrum of primary triple-negative breast cancers;Shah;Nature.,2012

3. Heterogeneity of neoplastic stem cells: theoretical, functional, and clinical implications;Valent;Cancer Res.,2013

4. Therapeutic implications of cellular heterogeneity and plasticity in breast cancer. itCell Stem Cell;Brooks,2015

5. Subclonal diversification of primary breast cancer revealed by multiregion sequencing;Yates;Nat Med.,2015

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Thienopyrimidine-Hydrazinyl Compounds Induce DRP1-Mediated Non-Apoptotic Cell Death in Triple-Negative Breast Cancer Cells;Cancers;2024-07-23

2. Spatial transcriptomic analysis of amelanotic acral melanoma versus pigmented acral melanoma reveals distinct molecular determinants;British Journal of Dermatology;2024-05-30

3. Exploring the interplay between triple‐negative breast cancer stem cells and tumor microenvironment for effective therapeutic strategies;Journal of Cellular Physiology;2024-05-28

4. The Potential of Stem Cells in Treating Breast Cancer;Current Stem Cell Research & Therapy;2024-04

5. Regulation of mRNA translation by estrogen receptor in breast cancer;Steroids;2023-12